menu
    • menu

    Company profile for Napo EU

    NEW Drugs in Dev: 2
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Napo EU S.p.A. is focused on developing crofelemer for the European market. Napo EU is the Italian subsidiary of Napo Pharmaceuticals, a commercial-stage pharmaceutical company based in San Francisco, California, that markets crofelemer in the US and is a wholly owned subsidiary of Jaguar Health. Napo Pharmaceuticals’ focus is on developing and commercializing novel, plant-based, sustainably derived prescription medicines fo...
    Napo EU S.p.A. is focused on developing crofelemer for the European market. Napo EU is the Italian subsidiary of Napo Pharmaceuticals, a commercial-stage pharmaceutical company based in San Francisco, California, that markets crofelemer in the US and is a wholly owned subsidiary of Jaguar Health. Napo Pharmaceuticals’ focus is on developing and commercializing novel, plant-based, sustainably derived prescription medicines for people with life-altering gastrointestinal (GI) distress—specifically chronic GI malabsorption or debilitating volume and frequency of GI output.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Napo EUItaly Flag
    Country
    Country
    Italy
    Address
    Address
    Corso Giacomo Matteotti Milano (MI), CAP 20121
    Telephone
    Telephone
    (415) 963-9938
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://napopharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/napopharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CGT Asia

    Not Confirmed

    envelop Contact Supplier

    CGT Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA Backs Crofelemer Trial Extension In MVID Diseases
    FDA Backs Crofelemer Trial Extension In MVID Diseases

    18 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-18/fda-feedback-supports-extension-phase-for-jaguar-healths-clinical-trial-of-crofelemer-for-treatment

    PHARMIWEB
    18 Mar 2026
    Share Share
    Jaguar Health Secures $3M Payment From Future Pak For Mytesi
    Jaguar Health Secures $3M Payment From Future Pak For Mytesi

    03 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-03/jaguar-health-secures-an-additional-3-million-payment-from-future-pak-for-mytesi-and-canalevia-ca1

    PHARMIWEB
    03 Mar 2026
    Share Share
    Jaguar Inks $38M U.S. Crofelemer License Deal With Future Pak
    Jaguar Inks $38M U.S. Crofelemer License Deal With Future Pak

    12 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-12/jaguar-health-enters-into-us-license-agreement-with-future-pak-for-crofelemer-providing-up-to-38

    PHARMIWEB
    12 Jan 2026
    Share Share
    Jaguar Health Announces Abstract Submission for Preliminary Data
    Jaguar Health Announces Abstract Submission for Preliminary Data

    15 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-15/jaguar-health-announces-abstract-submission-for-preliminary-data-from-us-investigator-initiated-tria

    PHARMIWEB
    15 Dec 2025
    Share Share
    Jaguar Health Strengthens Global IP With New Crofelemer Patent
    Jaguar Health Strengthens Global IP With New Crofelemer Patent

    24 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-24/jaguar-health-secures-new-patent-for-crofelemer-in-short-bowel-syndrome-strengthening-global-ip-pos

    PHARMIWEB
    24 Nov 2025
    Share Share
    Jaguar Health Provides Recap of November 8, 2025 Presentation
    Jaguar Health Provides Recap of November 8, 2025 Presentation

    13 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-13/jaguar-health-provides-recap-of-november-8-2025-presentation-on-groundbreaking-results-of-proof-of

    PHARMIWEB
    13 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search